These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30479925)

  • 1. Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories.
    Nishimura T; Akiyoshi K
    Adv Sci (Weinh); 2018 Nov; 5(11):1800801. PubMed ID: 30479925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransporting Self-Assembled Nanofactories Using Polymer Vesicles with Molecular Permeability for Enzyme Prodrug Cancer Therapy.
    Nishimura T; Sasaki Y; Akiyoshi K
    Adv Mater; 2017 Sep; 29(36):. PubMed ID: 28714209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable Biocatalytic Nanocomposite Hydrogel Factories for Focal Enzyme-Prodrug Cancer Therapy.
    Ono K; Hashimoto H; Katayama T; Ueda N; Nagahama K
    Biomacromolecules; 2021 Oct; 22(10):4217-4227. PubMed ID: 34546743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermoresponsive Carbohydrate-
    Okuno Y; Nishimura T; Sasaki Y; Akiyoshi K
    Biomacromolecules; 2021 Jul; 22(7):3099-3106. PubMed ID: 34165283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy.
    Japir AAMM; Ke W; Li J; Mukerabigwi JF; Ibrahim A; Wang Y; Li X; Zhou Q; Mohammed F; Ge Z
    J Control Release; 2021 Nov; 339():418-429. PubMed ID: 34662586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrageenan: A Wonder Polymer from Marine Algae for Potential Drug Delivery Applications.
    Qureshi D; Nayak SK; Maji S; Kim D; Banerjee I; Pal K
    Curr Pharm Des; 2019; 25(11):1172-1186. PubMed ID: 31465278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-Sorting Nanoreactors Based on Permeable Peptide Polymer Vesicles and Hybrid Liposomes with Synthetic Macromolecular Channels.
    Nishimura T; Hirose S; Sasaki Y; Akiyoshi K
    J Am Chem Soc; 2020 Jan; 142(1):154-161. PubMed ID: 31766845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Novel and Nanostructured Drug Delivery Systems for the Treatment of Oral Cavity Diseases.
    Hosseinpour-Moghadam R; Mehryab F; Torshabi M; Haeri A
    Clin Ther; 2021 Dec; 43(12):e377-e402. PubMed ID: 34844769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
    Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
    Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Nanoreactors as In Vivo Nanoplatforms for Cancer Therapy.
    Mukerabigwi JF; Ge Z; Kataoka K
    Chemistry; 2018 Oct; 24(59):15706-15724. PubMed ID: 29572992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AI-2 biosynthesis module in a magnetic nanofactory alters bacterial response via localized synthesis and delivery.
    Fernandes R; Bentley WE
    Biotechnol Bioeng; 2009 Feb; 102(2):390-9. PubMed ID: 18949758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer nanocompartments in broad-spectrum medical applications.
    Najer A; Wu D; Vasquez D; Palivan CG; Meier W
    Nanomedicine (Lond); 2013 Mar; 8(3):425-47. PubMed ID: 23477335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymersomes as nanoreactors for preparative biocatalytic applications: current challenges and future perspectives.
    Klermund L; Castiglione K
    Bioprocess Biosyst Eng; 2018 Sep; 41(9):1233-1246. PubMed ID: 29777296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoreactor-based catalytic systems for therapeutic applications: Principles, strategies, and challenges.
    Zhang D; Liu D; Wang C; Su Y; Zhang X
    Adv Colloid Interface Sci; 2023 Dec; 322():103037. PubMed ID: 37931381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanocarriers and nanoreactors: a survey of possible therapeutic applications.
    Onaca-Fischer O; Liu J; Inglin M; Palivan CG
    Curr Pharm Des; 2012; 18(18):2622-43. PubMed ID: 22512447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-functional silica-based mesoporous materials for simultaneous delivery of biologically active ions and therapeutic biomolecules.
    Zhu H; Zheng K; Boccaccini AR
    Acta Biomater; 2021 Jul; 129():1-17. PubMed ID: 34010692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.